---
date created: 2024-11-16
dg-publish: true
tags:
  - meds
---
**Class:**
- NMDA Receptor Antagonist

**Mechanism of Action (MOA):**
- Blocks NMDA receptors, reducing abnormal activity of glutamate in the brain, which is thought to contribute to symptoms of Alzheimer's disease.

**Indications/Uses:**
- Moderate to severe Alzheimer's disease

**Side Effects:**
- Dizziness
- Headache
- Confusion
- Constipation
- Hypertension

**Adverse Effects:**
- Severe allergic reactions (rare)
- Seizures (rare)

**Nursing Teaching and Implications:**
- Educate about taking the medication consistently, with or without food.
- Monitor cognitive function and assess for changes in behavior.
- Advise that therapeutic effects may take weeks to become apparent.
- Caution about potential dizziness and advise against operating heavy machinery until effects are known.

**Contraindications:**
- Known hypersensitivity to memantine